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Abstract
Copy-number variations (CNV), loss of heterozygosity (LOH), and uniparental disomy
(UPD) are large genomic aberrations leading to many common inherited diseases, cancers,
and other complex diseases. An integrated tool to identify these aberrations is essential in
understanding diseases and in designing clinical interventions. Previous discovery methods
based on whole-genome sequencing (WGS) require very high depth of coverage on the
whole genome scale, and are cost-wise inefficient. Another approach, whole exome ge-
nome sequencing (WEGS), is limited to discovering variations within exons. Thus, we are
lacking efficient methods to detect genomic aberrations on the whole genome scale using
next-generation sequencing technology. Here we present a method to identify genome-
wide CNV, LOH and UPD for the human genome via selectively sequencing a small portion
of genome termed Selected Target Regions (SeTRs). In our experiments, the SeTRs are
covered by 99.73%~99.95% with sufficient depth. Our developed bioinformatics pipeline
calls genome-wide CNVs with high confidence, revealing 8 credible events of LOH and 3
UPD events larger than 5M from 15 individual samples. We demonstrate that genome-wide
CNV, LOH and UPD can be detected using a cost-effective SeTRs sequencing approach,
and that LOH and UPD can be identified using just a sample grouping technique, without
using a matched sample or familial information.
Introduction
Copy-number variations (CNV)[1]and loss of heterozygosity (LOH)[2] are different types of
genomics aberrations. CNV is defined as a variation from the reference genome by a more
than 1Kbp DNA segment, either via duplication or deletion[3]. LOH is manifested by unusual
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long stretches of homozygous SNPs. When a LOH occurs without a change in copy number
(CN), i.e. that both copies are inherited from only one parent, it is called copy-neutral LOH, or
uniparental disomy (UPD)[4,5]. CNV, LOH, and UPD are important factors leading to many
common inherited diseases, cancers, and other complex diseases[6–10]. Thus, accurately iden-
tifying genome-wide CNV, LOH and UPD is essential in understanding diseases and in design-
ing correct clinical interventions.
For a long time, SNP genotyping arrays[11]and array Comparative Genomic Hybridization
(aCGH)[12] have been deemed as standard means to detect CNV or LOH. Those DNA micro-
arrays, however, suffer some common limitations—most notably that the measured CN ratio
from fluorescence intensities is noisy[13–16] and the experimental results require further ex-
amination from an experienced person.
With the rapid decrease in price and increase in accuracy with next-generation sequencing
(NGS), more and more CNV and LOH studies are turning to NGS. Four methods for genome-
wide CNV detection have been established recently based on whole-genome sequencing
(WGS) using NGS. There are: paired-end mapping, read-depth analysis, split-read strategies,
and sequence assembly comparisons[17–20]. These methods require high depth of coverage on
whole genome scale. Other approaches with low coverage depth on WGS cannot detect hetero-
zygous positions for LOH and UPD[21,22]. Another parallel method is to sequence only the
exome. The exome-only method detects CNVs associated with exons and typically small in
size (~100—200bp). Their distribution in the genome is uneven. Thus, exome-only sequencing
fails to capture a global picture of genome-scale aberrations.
A limited number of approaches have been developed for small CNV or LOH analysis using
target region(TR) sequencing[23,24]. The current TR-approaches in practice are also limited to
detect variations involving one or a few of exons. Most methods, based on TR sequencing,
eliminate bias (GC bias etc.) by using some correction methods; but it is known that some local
variations in depth-of-coverage cannot be removed by the GC-based correction[25] and the
non-contiguous nature of target regions poses a different challenge to computational methods.
For example, longer genes are on average better covered compared to shorter ones; and low-
complexity target regions usually have poor coverage. Further, most of them do not discrimi-
nate between two- and single-copy deletion and between three- and multiple-copy amplifica-
tions. They cannot predict exact copy number of a genomic segment and fail to identify large
LOH and UPD without a matched control or family members.
In summary, so far no method has been proposed to avoid the defects of WGS and TR se-
quencing in identifying all genome-wide CNV,LOH and UPD without a matched sample. To
address this issue, we elaborately designed a special genome-wide segmental partition termed
Selected Target Regions (SeTRs). SeTR is composed of evenly distributed small SNPs and short
random repeat markers and it collectively covers 1.46% of the whole genome (2.86G bp, hg19).
The average length of SeTRs’ probes is ~150bp and the median physical distance between two
adjacent probes is about 10.6kb. We also established a bioinformatics pipeline named ICLU
(Identifying genome-wide CNV, LOH and UPD). ICLU employs T-test to detect CNV using
the depth-of-coverage of targeted regions and employs F-test to call LOH using heterozygous
coefficient of polymorphic position. It combines CNV and LOH to infer UPD, and visualizes
genome wide alterations via Circos[26] (Fig 1). We used simulation data as well as real samples
with known variations to validate our method. We applied our method to detect genomic-wide
aberrations in 15 real samples. By grouping samples together, we are able to achieve variation
detection without using a matched sample or familial information. One shortcoming is that TR
sequencing cannot resolve novel, small variants (SNPs and indels) located within the designed
target regions. Aside from this minor problem, we believe TR sequencing technology has great
potential for studying genome-wide CNV, LOH, and UPD.
Identifying CNV, LOH and UPD by Targeted Sequencing
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Results
Evaluation of SeTR Sequencing
In this study, we have designed 278,800 probes that are small DNA segments selected from the
published human reference genome, Build 37.1, hg19. The total size of the probes is
41,795,106bp(~42Mb). Our probes cover 1.46% of the whole effective genome (2.86G bp,
hg19). The average length of probe is about 150bp and the median physical distance between
two adjacent probes is about 10.6kb genome wide (S1 Table and S1 Fig). We also vindicated
the distribution of SeTR probes on three real samples before the downstream analysis.
Three sequence libraries were generated from genomic DNA (gDNA) of three samples, in-
cluding two normal samples (YH and HG00537) and a Coriell Institute sample, GM50275,
known to contain a positive CNV. The three libraries were then sequenced via the Illumina
high throughput sequencing platform. After filtering out reads with low sequencing quality
scores (Q<20)[27] or with adapters’ sequence, the clean data was mapped to the human ge-
nome reference assembly (Build 37.1, hg19). 66.93%-67.87% of clean reads were aligned to tar-
get regions, representing 95.16%-97.09% of the uniquely mapped. Under the condition that the
mean target region coverage was 70 reads or above, the alignment results showed that 99.73%-
99.95% of the target regions were covered by at least one reads and over 99% by at least ten
reads (Table 1). This aligned coverage of target regions was better in evenness than the cover-
age from other capturing methods, such as exome capturing, with similar mean coverage[28].
The coverage depth distribution of target regions showed a similar Poisson distribution for
all three samples, indicating an even enrichment of the target regions (Fig 2A). Most SNPs’
sites called by GATK software have similar support reads for the non-reference allele and for
the reference allele, inferring good enrichment balance for the two haplotypes (Fig 2B).
Characteristics of depth-of-coverage and heterozygous coefficient in
SeTRs
To detect CNV, the depth-of-coverage of SeTRs was calculated from the re-corrected align-
ment results and then was transformed to preRi by dividing its coverage depth by the average
depth of all target regions for the sample(see Methods). We found that this preRi has large
Fig 1. Overview of the ICLU pipeline. The pipeline takes the raw FASTQ files or the aligned BAM files as
input, and outputs the genome-wide CNV, LOH and UPD results with visualization.
doi:10.1371/journal.pone.0123081.g001
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fluctuations on the whole genome scale, which is expected due to the characteristics of each tar-
get region and the different capture efficiency of the probes (Fig 3AB). In order to keep the rela-
tive stability of the fluctuations in contiguous target regions, two correction strategies were
applied:1) We selected the mean value of ten downstream target regions’ depth (TDmi) of the
target i region to replace TDi to get depth coefficient (Ri) using a smoothing fit. 2) We generate
Rm by dividing Ri with the geometric median of all Ris of in the same target i region in multiple
samples. The median of Ri, regarded as a robust baseline to reduce the adverse effect of experi-
mental conditions and capture efficiency, is essential to renormalize Ri. A few of Ris alone in
normal samples failed to be normalized to 1 by formulas (1,2,3,4,5) (see Methods)(Fig 3A).
After those smoothing and renormalization steps, the final corrected ratio (Rmi) showed much
smaller variability across the whole genome. It is much closer to the normal distribution with a
mean of 1(from 1.207 to 0.959) and a smaller standard deviation (from 0.54 to 0.29) than Ri
(Fig 3) in YH. When using the above approach to analyze the depth-of-coverage of SeTRs on
Table 1. Data production andmapping results for the three samples used.
Sample YH HG00537 GM50275
Target region(bp) 41,795,106 41,795,106 41,795,106
Raw reads 78,544,670 77,826,604 80,181,866
Raw data(Mb) 7,067.69 7,003.09 7,211.26
Clean reads 66,288,119 63,136,026 62,010,469
Clean data (Mb) 5,965.93 5,682.24 5,580.94
Clean reads mapped to genome (%) 99.29 98.13 98.14
Clean reads uniquely mapped to genome (%) 97.09 95.96 95.16
Clean reads mapped to target region (%) 67.43 66.93 67.87
Mean depth of target region (X) 70.89 68.15 67.3
Coverage of target region (%) 99.94 99.73 99.95
Fraction of target covered > = 4X (%) 99.9 99.52 99.89
Fraction of target covered > = 10X (%) 99.48 99.19 99.44
Fraction of target covered > = 20X (%) 96.65 96.57 96.34
Fraction of target covered > = 30X (%) 90.02 89.79 88.99
Fraction of target covered > = 40X (%) 80.03 79.01 77.81
doi:10.1371/journal.pone.0123081.t001
Fig 2. Characteristics of SeTRs in three real samples. (A) Distribution of coverage depth in SeTR; (B) The
distribution of supported non-reference and reference allele reads at SNPs’ sites.
doi:10.1371/journal.pone.0123081.g002
Identifying CNV, LOH and UPD by Targeted Sequencing
PLOS ONE | DOI:10.1371/journal.pone.0123081 April 28, 2015 4 / 18
chromosome 5 of GM50275 individual, a copy number loss event (del(5)(p14)) gradually
emerged (Fig 4), consistent with the known and confirmed result (Table 2).
To estimate LOH, polymorphic positions with high allele frequency between 0.1 and 0.9 in
the 1000 Genome SNPs Database (ftp://ftp.ncbi.nih.gov/1000genomes/ftp/release) in SeTRs of
samples were retained and the non-reference-allele or “B-allele” frequency (BAF) of these posi-
tions was substituted by heterozygous coefficient (denoted as RHet, see Methods) to represent
the heterozygous status of these local sites in SeTRs. In order to eliminate the individual back-
ground difference and give reasonable expression of RHet, median RHet was introduced. It is the
geometric median of all RHets for every polymorphic position in the collection of multiple sam-
ples. By RHet’s definition, if a LOH occurs in a sequenced region, the expected sets of RHets on
the sequenced regionequal0 and otherwise they should equal1. In practice, most of RHets or
median RHets were distributed between 0 and 1 across the whole chromosomes in one normal
sample or in multiple samples (Fig 5). PCR amplification bias in NGS[29] may cause a haploid
fragment pairs not equal in amounts. In our investigation, on chromosome 5p14 in GM50275
individual, a loss event happens, the sets of RHets were close to 0 (Fig 5) and it reveals obviously
Fig 3. Characteristics of three ratios in YH sample. (AB)The distribution of three ratios across Chromosome 5.The imaginary line (Ratio = 0.5) means the
CN equals to 1 and the imaginary line (Ratio = 1.5) CN equals to 3. After smoothing and renormalized steps, the fluctuation of ratios decreased gradually from
preRi (gray circle points) to Ri, and then to Rmi (black line). (C)The distribution of Ri in the whole genome;(D)The distribution of Rmi in the whole genome.
doi:10.1371/journal.pone.0123081.g003
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that there was a LOH. Based on this reasoning, an F-test is applied in our method to detect sig-
nificance increases in variance of RHets of a genomic region in a test sample from that of medi-
an RHets in the collection of multiple samples (see Methods).
The performance of ICLU
We first used simulated data and then real samples’ data to assess the accuracy and power of
our method for detecting genome-wide CNV. As our first step, we applied ICLU and CONTRA
developed on WEGS[24], to detect small CNV with sizes ranging from 450Kb to 3Mb, and to
identify the boundaries (break point detection) using the simulated whole genome sequencing
data. With the same SeTRs, we simulated the Illumina paired-end (PE) reads with ~30X cover-
age of 8 individual samples using wgism (website:https://github.com/lh3/wgsim) but only per-
formed the simulation on Chromosomes 19 and 20 of hg19 because of limited computing
Fig 4. Characteristics of preRi and Rmi on Chromosome 5 of GM50275 individual.
doi:10.1371/journal.pone.0123081.g004
Table 2. The detected results of genome-wide CNV of 15 confirmed samples.
Sample Confirmed ICLU(~42Mb SeTRs) ICLU(~5Mb SeTRs)
CNV CNV CN CNV CN
YH 46,XY 46,XY 2 46,XY 2
HG00537 46,XX 46,XX 2 46,XX 2
GM50178 46,XX,del(5)(p15.3) 46,XX,del(5)(p15.3) 1 46,XX,del(5)(p15.3) 1
GM50275 46,XY,del(5)(p14) 46,XY,del(5)(p14) 1 46,XY,del(5)(p14) 1
GM12959 46,XY,del(1)(q43) 46,XY,del(1)(q43q44) 1 46,XY,del(1)(q43q44) 1
GM11419 49,XYYYY 49,XYYYY 4 49,XYYYY 4
GM22364 46,XY,dup(15)(q11q12) 46,XY,dup(15)(q11q12q13.1) 3 46,XY,dup(15)(q11q12q13.1) 3
GM05047 46,XY,dup(10)(q11.2q23.2) 46,XY,dup(10)(q11.2q23.2) 3 46,XY,dup(10)(q11.2q23.2) 3
GM50142 46,XY,dup(18)(q21.2q22) 46,XY,dup(18)(q21.2q22) 3 46,XY,dup(18)(q21.2q22) 3
GM12074 46,XY,del(16)(q22q23) 46,XY,del(16)(q22q23) 1 NA NA
GM10922 46,XY,del(3)(p25) 46,XY,del(3)(p25p26) 1 NA NA
GM10932 46,XY,del(8)(p23) 46,XY,del(8)(p23) 1 NA NA
GM03623 48,XXX,+18 48,XXX,+18 3,3 48,XXX,+18 3,3
GM05875 46,XX,del(16)(p12p11.2) 46,XX,del(16)(p12p11.2) 1 46,XX,del(16)(p12p11.2) 1
GM08696 46,XY,dup(18)(q21.3q12.1) 46,XY,dup(18)(q21.3q12) 3 46,XY,dup(18)(q21.3q12) 3
Note: “NA” means there is no result due to failing to make a NGS library.
doi:10.1371/journal.pone.0123081.t002
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resource. The simulated sequence data has a median insert size of 200bp and a read length of
100bp. 3 of 8 individual samples are designed as true positive CNV samples. The other 5 sam-
ples are designed as normal, and are used as a control set so as to create a robust base line. All
these simulated data received CNV analysis using ICLU pipeline described above (Fig 1) with
parameters-M 10,-P 0.05 and CONTRA with default parameters. ICLU analysis results cap-
tured all 9 true positive events containing CN, and no false positive with 100% of sensitivity
and 100% of specificity(S2 Table and S2 Fig). In comparison, CONTRA reports 11 CNV
events, 8 are true positive and 3 false positive, thus behaving with 88.9% of sensitivity and
66.7% of specificity(S2 Table)
In the second step, we applied ICLU on 55X~90X of SeTRs sequencing data of 15 real
human individuals, including 2 normal samples and 13 samples with true positive CNV events,
all of which have been studied before. A robust base line of median Ri was constructed from 15
samples, and all samples were searched for CNVs over 1Mb at the p-value of 0.05 with the min-
imal number of probes setting at 45 or the minimal size of region at ~0.5Mb (45~10kb =
~450kb). In total, 13 out of 15 test samples were identified with CNVs over 4Mb or with aneu-
ploidies, including 11 events of CNVs from 11 samples and 3 aneuploidies from 2 samples.
Among those, 7 events were single-copy deletions, 6 events three-copy amplifications, and 1
event a four-copy amplification on chromosome Y. In summary, the CNV results estimated by
ICLU were highly consistent with confirmed CNV results (Table 2). The results demonstrated
that ICLU in this case presented 100% sensitivity and 100% specificity(S3 Table).
Fig 5. The distribution of RHet across Chromosome 5 in YH, multiple samples and GM50275. (A) RHets
for the normal sample, YH; (B) Median RHets for multiple samples; (C) RHets for the positive sample,
GM50275.
doi:10.1371/journal.pone.0123081.g005
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We also studied the ability of our method at different coverage depth of SeTRs by gradually
decreasing the depth of SeTRs from 55X~90X to 5X. The performance of ICLU did not degen-
erate significantly as coverage depth decreases. Almost all known CNV were discovered with
no false positive predictions (S4 Table), even at its lower depth level of 8X.If coverage is below
8X,CNV calls by ICLU are no longer reliable (S3 Fig). There is one exception concerning an an-
euploidy prediction on chromosome Y of sample GM11419 with 30X average coverage depth.
Its computed mean CN is 3.497, giving a false predicted CN of 3 after round off (whereas the
correct CN should be 4). In this case, the density of probes on chromosome Y is not high
enough (S1 Table) to keep Rmi stable with lowered average coverage. This problem can be fixed
by increasing the probe density at this region without raising coverage depth, or, of course, by
increasing the average coverage depth as was shown before.
We also used ICLU to analyze LOH and UPD events within these 15 real samples on
55X~90X depth-of-coverage of SeTRs sequencing data. 8 events of LOH, whose sizes are larger
than 5Mb, were observed under the p-value of 0.01; and all boundaries of LOH (CN = 1) were
consistent with CNV results. Furthermore, combining with CNV (CN = 2) and LOH results, 3
isodisomy events of UPD were identified (Table 3). Without their familial information or
matched samples, we cannot confirm the accuracy of these findings. But at least in theory,
when CN was equal 1, LOH should happen, and that was captured in our results.
Moreover, we redesigned another smaller SeTRs set according to the same designing ap-
proach as described in Methods, the total size of which is 4,926,646bp(~5Mb).We used ICLU
to analyze the above cell-line samples and it is demonstrated that the ICLU based on this
SeTRs(~5Mb) has as good performance in detecting CNVs as that based on SeTRs(~42Mb)
(Table 2 and S3 Table). This indicates that ICLU is flexible with its number of probes, and the
results produced by ICLU are reproducible even though the SeTR probes are significantly re-
duced. Of course, the resolution power on CNV boundaries will drop as number of probes are
decreased systematically. We also tested ICLU algorithm on 5 samples from aborted fetuses
Table 3. The detected results of genome-wide LOH and UPD in15 test samples.
Sample Chromosome Start End Size(>5M) LOH CN
YH - - - - - -
HG00537 - - - - - -
GM50178 chrX 103489643 108870605 5.38 UPD 2
chr5 38139 5893356 5.86 LOH_nonUPD 1
GM50275 chr5 18601469 28281734 9.68 LOH_nonUPD 1
GM12959 chr1 242808483 248553940 5.75 LOH_nonUPD 1
chr10 38160098 43475568 5.32 UPD 2
GM11419 chr3 46077525 51871405 5.79 UPD 2
GM22364 - - - - - -
GM05047 - - - - - -
GM50142 - - - - - -
GM12074 chr16 67747306 75697469 7.95 LOH_nonUPD 1
GM10922 chr3 75084 11736290 11.66 LOH_nonUPD 1
GM10932 - - - - - -
GM03623 - - - - - -
GM05875 - - - - - -
GM08696 - - - - - -
Note: “LOH_nonUPD” means there is a LOH, but not UPD; “-” means there is no LOH events in this sample.
doi:10.1371/journal.pone.0123081.t003
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with unknown result and then validated these predictions by WGS method[30]. The data
showed that ICLU, just as the WGS approach, can produced highly reliable results (S5 Table).
Visualization
In our study, Circos[26] is used to plot circular maps for a genome-wide view of relationships
among genomic intervals. It depicts the details of whole-genome CNV and LOH features and
is useful for a comprehension of the global picture. The figure is consisted of four parts from
outside to inside: I) the chromosome ideograms in a pter-qter orientation, clockwise with the
centromeres in red; II) the distribution of Rmi across whole genome with blue lines and the
value of Rmi is from 4 to 0; III) the p-value views of heterozygous state; IV) the distribution of
RHet across whole genome with orange spots and the value of RHet is from 1 to 0. As shown in
Fig 6, one can see that there are 1 deletion and 1 LOH on chromosome 5p14 of the individual
GM50275. Results for other individuals are shown in S4 Fig.
Discussion
In this paper, we have proposed a novel integrated method, a selected target region approach
(SeTR approach), for detecting genome-wide structural variations such as CNV, LOH and
UPD. SeTRs are selected genome-wide with mean probe length of 150bp, the average distance
Fig 6. The Circos result of GM50275. In part II, CN can be predicted by dividing Rmi by 0.5 and a red line
indicates a loss event and a green line displays a gain event.
doi:10.1371/journal.pone.0123081.g006
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among them of ~10kb, and the cumulative size of ~42Mb. Once sequenced to a certain depth,
captured sequences of this set can be effectively used to detect structural variations and geno-
mic aberrations for the entire genome. We also have developed a software package, ICLU, that
uses statistical algorithms to detect of CNV, LOH and UPD for the SeTR sequencing approach.
In addition, if one is only concerned about a specific CNV disease, or on a specific chromo-
some, or a certain collection of genomic hot spots, one can use a subset of our SeTRs within the
interesting regions and our method will just work effectively as well.
With this selected target region approach, we don’t need to sequence the entire genome in
order to detect CNVs. Our current approach only requires the sequencing of a fraction of the
genome, about ~42Mb in size, or ~1.5% of the genome. In the extreme case, we can even lower
the set to a minimal size of ~5Mb, or about ~0.17% of the genome, and still make correct pre-
dictions. With this approach, we can bring the coverage depth in the targeted regions much
higher, and in the meantime, keep the overall cost of sequencing much smaller than that of a
genome-wide sequencing approach. With the genomic sequencing cost dropping exponential-
ly, our approach is a low-cost, high efficient method for detecting large structure aberrations
such as CNV, LOH and UPD. It has the potential to displace other methods, such as the micro-
array based approaches, and the WGS methods.
At any specific location within genome, we perform noise reduction and signal smoothing
using the medium coverage value for the entire collection of samples. This medium value mat-
ters a lot to us. Presumably, the healthy samples should far exceed diseased ones in a popula-
tion for any specific region in question; otherwise one would be prone to make incorrect CNV
calls. In the extreme, a sample size of 3 with at most 1 CNV in any specific genomic spot for
the entire genome would be the absolute limit in applicability for our approach. In practice, for
our method to make correct predictions, we would require a substantially larger collection of
samples. Here we propose that a meaningful threshold of 8 samples as the minimum, and the
samples should come from a random population.
Another limitation on our method concerns the detection of breaking points, or the exact
CNV transition locations. We assume that each of our probes is located either entirely out of a
CNV or entirely within. As we only sequence the genomic regions of SeTRs, a breaking point
cannot be resolved beyond the two neighboring probes. What we do convey is to indicate that
the two neighboring probes fall into two different CN regions. We also do not attempt to re-
solve any breaking point within a single probe, although in theory that can happen in ~1.5%
cases (which is the coverage of our probes for the genome). So, our current limit of detection
resolution is ~10K bases. A deeper read depth of SeTRs or a higher density of probes can im-
prove the statistical power of CNV and LOH detection, and can also discover CNV events
smaller in size. In contract, the approach of paired-end mapping[31,32] and de novo assembly
of a genome[33] on WGS data would be more suitable to pinpoint breakpoints, to identify
novel cross-chromosome events, and to completely characterizing the full spectrum of CNV
and LOH.
In our study, 15 real samples captured by SeTRs kits and 8 simulated WGS samples are ana-
lyzed by ICLU. As the depth of coverage of target regions decreases gradually, the CNV results
persist to be consistent with known karyotypes of real samples. True positive events of ~500kb
CNVs in simulated samples have all been identified. Due to lack of parental information,
LOHs and UPDs have not been validated. It is our understanding that LOH should happen
with CN equals one. These events (CN = 1 and size>5Mb) in real samples are all correctly de-
tected; and this reflects that our method for LOH detection is feasible. Moreover, when the
RHets of a genomic region presented is mainly around 0.5, such as dup(10) (q11.2q23.2) in
GM05047 (S5 Fig), it indicates that the event’s CN may be changed to three. This appearance
could also be used to support the accuracy in detecting CNV in ICLU.
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In previous studies, people have developed CNV methods for CNVs in only exome regions
[23,24,34]. We can combine these exome probe sets with our SeTR set. The combined probe
set will be able to detect exon SNPs, indels, and identify genome-wide CNV and LOH for dis-
eases. This approach may be financially meaningful, as we are only sequencing the minimum
amount of the genome, yet we will have the ability to address the most urgent questions such
as protein integrity and genomic integrity the same time.
Conclusion
With the rapid development of sequencing technology and the fast decrease in price of NGS,
detecting genomic alterations using a targeted sequencing strategy has the promises of high
throughput and of low price. Price wise it should be less costly than both the microarray-based
techniques and the WGS strategy. The targeted sequence data set offers a quick insight into
CNV and LOH for specific diseases[35,36] or phenotypes in concern. Per conventions pro-
posed in Itsara’s study, CN variants at the size larger than 500kb would usually be considered
pathogenic in a clinical diagnostic setting[37]. This size fits well above our detection limit of
10kb. Therefore, our approach can detect all CNV events defined by current clinical standard.
Our selected targeted region strategy, coupled with a much smaller size of sequenced genomic
region and a decreased sequencing coverage depth, has tremendous financial advantages over
other methods in clinics today. In addition, SeTRs sequencing can be combined with the se-
quencing of other genomic regions of interest, such as exomic regions to form an economic
way of discovering genetic variations that have significant impact on human health[38].
Materials and Methods
Designing SeTRs
Genomic regions with extreme GC content (high or low) or with high polymorphism rates
negatively impact their PCR or target capture efficiency[23,39]. In some previous studies, GC-
content adjustment and mappability corrections have been applied in computation to remove
experimental bias[22,40–42]. In our study, we select special target regions, called evenly distrib-
uted selected target regions (SeTRs) to avoid coverage bias due to sequence content. We select
candidate SeTRs using the following criteria: (i) the uniqueness and stability properties of the
region. We require less polymorphism and a modest GC content; (ii) a small number of sparse
SNPs within to detect LOH, and that these SNPs are present with high frequency in population;
(iii) the probes are relatively uniform in distribution within the entire genome. Each target re-
gion is captured by one and only one probe.
The set of SeTR locations across the entire genome has been selected by the following steps:
i. SNPs set1: Based on SNPs database of the 1000 Genome Project (web: ftp://ftp.ncbi.nih.gov/
1000genomes/ftp/release/), SNPs with allele frequency (AF) ranging 10% to 90% in popula-
tion have been retained as candidates. A portion of clustered SNPs, i.e. those located within
the neighborhood of 100bp of another selected SNP, are removed.
ii. SNPs set2: SNPs set1 is filtered further using the reference genome. We construct short se-
quences around each SNP of 100 bases in length, using 50bp upstream and 50bp down-
stream from the SNP site. These short sequences are then mapped to the reference genome
by BLAST[43]. If the alignment for a short sequence shows no mismatch for the best map-
ping and within less than 5% mismatch by the second best mapping, the corresponding
SNP is retained in SNPs set2.
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iii. SNPs set3: Based on SNPs set2, the SNPs which are evenly distributed on the whole genome
are selected as final selected SNPs. In our study, the ideal physical distance between two ad-
jacent SNPs is set at 10k base. If an interval of 10k size contains more than one SNP in
SNPs set2, only one is kept. SNPs set3 may contain large gaps within the neighboring
SNPs.
iv. Final set for probe locations: For SNPs set3, if the physical distance of two adjacent SNPs
was more over 10k base, one or more selected target locations, selected to be evenly distrib-
uted within this gap region, are inserted. These additional locations make our collection of
SeTR locations complete. We now have achieved a set of locations that are relatively evenly
distributed across of the entire genome.
The typical gap size between two neighboring probe locations is around 10k base. The loca-
tion may be a SNP location from the 1000 Genome Project, or it may simply be a sequenced lo-
cation within the reference genome. In location selection, given the requirements of achieving
a relative evenness in distribution, but not an absolute evenness, we do have the freedom of
avoiding simple repetitive regions, and the regions with extreme GC values.
The source of samples and simulated data
The cell lines of 13 samples have been bought from The Coriell Institute, containing 2 aneu-
ploid samples and 11 micro deletion or duplication samples. All of their karyotype results and
catalogue ID (S6 Table) can be found from the webpage (http://ccr.coriell.org/Default.aspx?
public = true) using GM id. In addition, the YH sample, a healthy Chinese individual, and the
HG00537 sample (www.1000genomes.org) with normal karyotype and 5 DNA samples from
aborted fetuses were used in our evaluation of the method. We also used simulated data for
evaluation. A collection of 8 WGS data were generated via computer simulation, with the sam-
ples containing a total of 9 true CNV events.
Sequencing read mapping
After the whole genome shotgun library was constructed, the target PCR products captured by
SeTRs kits were sequenced on the Illumina HiSeq2000 sequencer following manufacturer’s in-
structions. Raw sequencing data was filtered by some bioinformatics screens (screening out
low quality reads and contaminated reads by using adapter and bacteria sequences). The re-
maining data were mapped to the reference human genome (hg19, Build 37.1) using BWA[44]
with default parameters. We then process the alignments by using SAMtools[45] to remove
PCR duplications. We also run local realignment around indels and base quality score recali-
bration employing the Genome Analysis Tool Kit (GATK) software[46].
Genome-wide CNV screening
According to re-alignment results, the first step was to calculate the depth of coverage in every
target region, denoted as TDi (i.e. Target Depth for region i). Then, each TDi was corrected to
TDmi using moving average in order to ensure the continuity and stability of fluctuation in ad-
jacent regions. TDmi was then normalized by dividing by TDmi (the average TDmi of all target
regions for all autosomal chromosomes) to get the depth coefficient Ri and then divide Ri by
the median Ri from multiple samples’ target region i to get Rmi.
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The relevant computation formula is as follow:
TDi ¼ Tibase=Tilen 1
TDmi ¼ ð
Xi
iþn TDiÞ=ðnþ 1Þ; n  10 2
TD ¼ ð
Xi
iþn TDiÞ=ðnþ 1Þ 3
TDm ¼ ð
Xi
iþn TDmiÞ=ðnþ 1Þ 4
Ri ¼ TDmi=TDm 5
preRi ¼ TDi
.
ð
X1
N
TDiÞ
.
N

6
Note: Tibase was the number of aligned bases in the region i and Tilen was its length.
In theory, all Rmi from multiple samples in the specific region i follow normal distribution.
For a given test sample in region i, T-test was adapted to detect a CNV signal using parameters
estimated from the collection of samples.
t ¼ ðRmi1  Rmi2Þ  ðm1  m2Þffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðn11ÞS21þðn21ÞS22
n1þn22 ð 1n1 þ 1n2Þ
q  tn1þn22 7
When the number of test samples was 1 and the number of multiple samples was n, under
the condition of the same Rmi distribution in each population, formula (7) can be simplified to:
t ¼ Rmi test  Rmi multipleffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
S2multipleð1þ 1nÞ
q 8
According to formula (8), a T-score and a p-value of each region i can be calculated. A re-
gion with p-value less than 0.05 was considered as a CNV signal in our study; and copy number
for the region was simply predicted by dividing Rm by 0.5 and taken it to the nearest integer
(the nearest integer function):CN = int(Rmi/0.5). Based on the p-value from T-test of a target
region, a pseudo signal was appended to each probe to indicate whether it was implicated in
the CNV region for the next step. Then, neighboring target regions having same copy numbers
will be merged together to form larger intervals across the entire chromosome. Here is an idea
on merging neighboring target regions into large intervals: A continuous 4 target regions was
set as the minimum interval size if they had the same direction of copy number change (T-
score<0 or>0) and 3 of their p-values were less than the first threshold value (i.e. 0.05, com-
mon threshold set for tests of significance), and the fourth p-value should not exceed a second
threshold (set at 0.2,i.e. Four times the first threshold value). Once meeting these condition, all
continuous 4 target regions would be mark ‘-’ or ‘+’ as a pseudo signal. With the same pseudo
signal, the two sets of {i..i + k; k 3, i 1; i, k 2 n} and {j..j + l; l 3, j i + k; j, l 2 n} that
were separated by less than 5 target regions, i.e. j−(i + 3) 5, would be merged as a single con-
tiguous region of {i..j + l}. By analogy, for the merge large sets of {i..N; N 4, i 1; N, i 2 n},
T-test was applied again between the test sample and the multiple samples using Rmi for the re-
gions of {i..N; N 4, i 1; N, i 2 n} as formula (9) and (10) showed. After this heuristic
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approach, the boundary, size and CN of {i..N; N 4, i 1; N, i 2 n} would be reported.
Zi ¼ Rmi test  Rmi multiple 9
t ¼
Xi
N
Zi
,
ðN  iþ 1Þ
SZi

ffiffiffiffiffiffiffi
Ni
p
 tðN  iÞ 10
Genome-wide LOH and UPD screening
SNP positions with allele frequencies between 0.1 and 0.9 in the 1000 Genome SNPs Database
in the target regions of samples are used to detect heterozygosity. For the position i, the B-allele
count is the number of reads with non-reference calls at this position. The B-Allele Frequency,
aka BAF, is the B-allele count divided by the total number of reads mapped to position i. RHet,
the heterozygosity advantage rate of the position i, is calculated by formula (11) and it repre-
sents the heterozygous state of position i.
RHet ¼ min
BAF
1 BAF ;
1 BAF
BAF
 
;RHet  ½0; 1 11
If position i appears to be an absolute heterozygous state, its RHet would be 1. On the con-
trary, when the RHet equals 0, position i is completely homozygous. An F-test has been applied
to detect LOH in whole genome using SD of RHets as follow: In the test sample, a subset of
RHets, has been constructed from the position i to j, denoted by Tij = {RHet_i, RHet_i+1,. . ., RHet_j;
i, j 2 n}. The corresponding,Mij ¼ f~RHet i; ~RHet iþ1; . . . ; ~RHet j; i; j 2 ng could be identified from
multiple samples, here ~RHet i denotes the median value of RHet_is for all samples at the position
i. Standard deviation (SD) of Tij was compared with SD of Mij by F-test to accept the null hy-
pothesis (H0) or the alternative hypothesis (HA) under the threshold of the p-value 0.01. If the
p-value of Tij is lower than 0.01, HA is accepted. It means that the subset of Tij has lost hetero-
zygosis comparing with the multiple samples. See formulas below for calculation details.
S2test ¼
X
irj
ðRtest r  Rtest rÞ
2
n 1 12
S2mul ¼
X
irj
ðRmul r  Rmul rÞ2
n 1 13
S2max ¼ maxfS2test; S2mulg; S2min ¼ minfS2test; S2mulg 14
Fupper ¼
S2max
S2min
; dftest ¼ dfmul ¼ n 1 ; Funder ¼
S2min
S2max
; dftest ¼ dfmul ¼ n 1 15
p value ¼ pupper þ ð1 punderÞ 16
We scan the continuous sets of {Tk, Tk + 1,. . .,Tl; k, l 2 n; l−k 3}, and initiate a LOH inter-
val if p-value is less than 0.01 for 3 continuous probes. Thus, our minimal LOH event has
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interval size spanning 3 probes. We extend this LOH by adding neighboring probes with small
p-values. We allow the continuous expansion of LOH region if only one probe has p-value
greater than 0.01 but the mean p-value for the entire region {Tk, Tk + 1,. . .,Tl; k, l 2 n; l−k 3}
is still less than 0.1. In another word, if the p-value of {Tk, Tk + 1,. . .,Tl; k, l 2 n; l−k 3} of the
extended region is smaller than 0.01,HA: σtest 6¼ σmul is accepted and that {Tk, Tk + 1,. . .,Tl; k, l
2 n; l−k 3} is predicted as a larger LOH.
The isodisomy of UPD occurs when a person receives two copies of a part or entire chromo-
some from one parent because of a duplication event. Integrating the results from genome-
wide CNV computation and heterozygosis screening, the isodisomy can be evaluated by apply-
ing this definition. If a segment presents that an LOH event has happened and the copy num-
ber is normal at the same time, we can conclude that the segment is an isodisomy.
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